S. Galluzzi

发表

Brain atrophy in Alzheimer’s Disease and aging

P. Bosco, G. Frisoni, Lorenzo Pini, 2016, Ageing Research Reviews.

Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC

Nick C Fox, N C Fox, P. Scheltens, 2003, Journal of neurology, neurosurgery, and psychiatry.

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

K. Blennow, J. Molinuevo, B. Winblad, 2017, Alzheimer's & Dementia.

Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study

H. Möller, B. Dubois, A. Bokde, 2016, Psychiatry Research: Neuroimaging.

Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study

A. Chincarini, G. Frisoni, A. Drzezga, 2014, NeuroImage: Clinical.

Age at onset reveals different functional connectivity abnormalities in prodromal Alzheimer’s disease

G. Frisoni, Lorenzo Pini, M. Pievani, 2020, Brain Imaging and Behavior.

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.

P. Rossini, J. Molinuevo, O. Blin, 2019, Journal of Alzheimer's disease : JAD.

The Italian Brain Normative Archive of structural MR scans: norms for medial temporal atrophy and white matter lesions

Marina Boccardi, Andrea Falini, Alberto Beltramello, 2009, Aging clinical and experimental research.

Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.

Nicola Toschi, Karl Herholz, Hovagim Bakardjian, 2015, Journal of Alzheimer's disease : JAD.

Mild cognitive impairment: Clinical features and review of screening instruments

L. Ferrucci, G. Frisoni, S. Galluzzi, 2001, Aging.

Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease

S. Lehéricy, B. Dubois, A. Vighetto, 2016, Neuropharmacology.

Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.

A. Chincarini, G. Frisoni, P. Mecocci, 2019, Journal of Alzheimer's disease : JAD.

Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.

G. Frisoni, A. Drzezga, R. Perneczky, 2015, Journal of Alzheimer's disease : JAD.

Visual Versus Semi-Quantitative Analysis of 18 F-FDG-PET in Amnestic MCI: An

G. Frisoni, R. Perneczky, S. Galluzzi, 2014 .

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.

Olivier Rouaud, Christine Delmaire, Didier Dormont, 2016, The Journal of clinical psychiatry.

Medical Informatics Platform (MIP): A Pilot Study Across Clinical Italian Cohorts

E. D’Angelo, Ferath Kherif, S. Cappa, 2020, Frontiers in Neurology.

The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study

P. Bosco, J. Molinuevo, A. Chincarini, 2017, Alzheimer's & Dementia.

Norms for imaging markers of brain reserve.

G. Frisoni, M. Pievani, E. Cavedo, 2012, Journal of Alzheimer's disease : JAD.

Development of a CT-based weighted rating scale for subcortical cerebrovascular disease sensitive to mild clinical symptoms

G. Frisoni, C. Testa, S. Galluzzi, 2002, Journal of the Neurological Sciences.

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

Roy W Jones, F. Jessen, A. Monsch, 2015, Alzheimer's & Dementia.

Brain Metastases from Primary Bronchial Carcinoma: A Statistical Study of 741 Necropsies

S. Galluzzi, P. Payne, 1956, British Journal of Cancer.

Topographic correspondence between white matter hyperintensities and brain atrophy

G. Frisoni, C. Testa, F. Sabattoli, 2006, Journal of Neurology.

Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study

G. Frisoni, A. Falini, H. Hampel, 2019, Aging Clinical and Experimental Research.

Prescription and choice of diagnostic imaging by physician specialty in Alzheimer’s Centers (Unità di Valutazione Alzheimer — UVA) in Northern Italy

G. Frisoni, S. Galluzzi, R. Riello, 2005, Aging clinical and experimental research.

Prescription patterns and efficacy of drugs for patients with dementia: physicians’ perspective in Italy

G. Frisoni, S. Galluzzi, C. Geroldi, 2007 .

Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)

P. Rossini, J. Molinuevo, O. Blin, 2017, Neurobiology of Aging.

Multi-Center Comparison of Medial Temporal Atrophy in Patients with Alzheimer’s Disease – Data from the ICTUS Study

P. Scheltens, G. Frisoni, B. Vellas, 2008, Dementia and Geriatric Cognitive Disorders.

Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia

G. Frisoni, S. Galluzzi, F. Tagliavini, 2022, Alzheimer disease and associated disorders.

Hashimoto's Encephalopathy in the Elderly: Relationship to Cognitive Impairment

G. Frisoni, S. Galluzzi, C. Geroldi, 2002, Journal of geriatric psychiatry and neurology.

A low-dimensional cognitive-network space in Alzheimer’s disease and frontotemporal dementia

M. P. van den Heuvel, S. D. de Lange, Lorenzo Pini, 2022, bioRxiv.

Cognitive and biological effects of citrus phytochemicals in subjective cognitive decline: a 36-week, randomized, placebo-controlled trial

G. Frisoni, M. Pievani, S. Galluzzi, 2022, Nutrition Journal.

Coma in a patient with Alzheimer's disease taking low dose trazodone and ginkgo biloba

G. Frisoni, S. Galluzzi, G. Binetti, 2000, Journal of neurology, neurosurgery, and psychiatry.

Medial temporal atrophy in early and late-onset Alzheimer's disease

Marina Boccardi, Martina Bocchetta, Giovanni B. Frisoni, 2014, Neurobiology of Aging.

Age at onset reveals different functional connectivity abnormalities in prodromal Alzheimer’s disease

G. Frisoni, Lorenzo Pini, M. Pievani, 2020, Brain Imaging and Behavior.

Plasma A (cid:2) 42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study

P. Rossini, J. Molinuevo, O. Blin, 2019 .

APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease

Paul M. Thompson, Giovanni B. Frisoni, Michela Pievani, 2011, NeuroImage.

White matter damage in Alzheimer disease and its relationship to gray matter atrophy.

Massimo Filippi, Federica Agosta, Stefania Sala, 2011, Radiology.

The Vascular Impairment of Cognition Classification Consensus Study

L. Leach, P. Langhorne, C. Caltagirone, 2017, Alzheimer's & Dementia.

Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly

G. Frisoni, S. Galluzzi, O. Zanetti, 2017, Neurobiology of Aging.

Association of postoperative delirium with markers of neurodegeneration and brain amyloidosis: a pilot study

G. Frisoni, S. Morzenti, G. Annoni, 2018, Neurobiology of Aging.

Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study

L. Leach, P. Langhorne, C. Caltagirone, 2018, Alzheimer's & Dementia.

The effect of white matter lesions on cognition in the elderly—small but detectable

Massimo Filippi, Leonardo Pantoni, Samantha Galluzzi, 2007, Nature Clinical Practice Neurology.

Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocol

G. Frisoni, S. Galluzzi, C. Geroldi, 2020, Alzheimer's Research & Therapy.

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

J. Berkhof, P. Scheltens, W. Maier, 2019, The Lancet Neurology.

Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.

P. Rossini, J. Molinuevo, O. Blin, 2019, Journal of Alzheimer's disease : JAD.

paper of the EADC cerebral blood flow and metabolism: consensus regional subcortical cerebrovascular disease, and Neuroimaging tools to rate regional atrophy,

P. Robert, L. Wahlund, S. Galluzzi, 2005 .

Disclosure of Genetic Risk Factors for Alzheimer’s Disease to Cognitively Healthy Individuals—From Current Practice towards a Personalised Medicine Scenario

G. Frisoni, M. Pievani, S. Galluzzi, 2022, Biomedicines.

Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE ϵ4 carriers

Giovanni B. Frisoni, Mojtaba Zarei, Nicola Filippini, 2009, Journal of magnetic resonance imaging : JMRI.

Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia

Marina Boccardi, Andrea Soricelli, Panteleimon Giannakopoulos, 2011, Psychiatry Research: Neuroimaging.

Association of blood pressure and genetic background with white matter lesions in patients with mild cognitive impairment.

Cristina Geroldi, Giuliano Binetti, Samantha Galluzzi, 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

CSF cutoffs for MCI due to AD depend on APOEε4 carrier status

P. Rossini, J. Molinuevo, O. Blin, 2019, Neurobiology of Aging.

Mild cognitive impairment with suspected nonamyloid pathology (SNAP)

Stephen F. Carter, W. M. van der Flier, P. Scheltens, 2015, Neurology.

White matter lesions in the elderly: Pathophysiological hypothesis on the effect on brain plasticity and reserve

Giovanni B. Frisoni, Massimo Filippi, Leonardo Pantoni, 2008, Journal of the Neurological Sciences.

The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia

Marina Boccardi, Cristina Geroldi, Alberto Beltramello, 2003, Neurobiology of Aging.

Hippocampal shape differences in dementia with Lewy bodies

Paul M. Thompson, Marina Boccardi, Giovanni B. Frisoni, 2008, NeuroImage.

Supporting evidence for using biomarkers in the diagnosis of MCI due to AD

G. Frisoni, S. Galluzzi, G. Amicucci, 2013, Journal of Neurology.

Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults

G. Frisoni, S. Galluzzi, G. Amicucci, 2012, Alzheimer's & Dementia.

The new Alzheimer’s criteria in a naturalistic series of patients with mild cognitive impairment

G. Frisoni, S. Galluzzi, G. Amicucci, 2010, Alzheimer's & Dementia.

Distinct cerebrospinal fluid amyloid‐beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia

G. Frisoni, S. Galluzzi, G. Amicucci, 2012, Electrophoresis.

Imaging, subjective complaints, and MCI: 30 years before

G. Frisoni, S. Galluzzi, 2008, The journal of nutrition, health & aging.

Norms for Automatic Estimation of Hippocampal Atrophy and a Step Forward for Applicability to the Italian Population

P. Rossini, S. Cappa, G. Frisoni, 2021, Frontiers in Neuroscience.

Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.

P. Rossini, J. Molinuevo, O. Blin, 2019, Journal of Alzheimer's disease : JAD.

Preliminary Evidence of Validity of the Revised Criteria for Alzheimer Disease Diagnosis: Report of 2 Cases

D. Perani, G. Frisoni, S. Galluzzi, 2010, Alzheimer disease and associated disorders.

Mild cognitive impairment with subcortical vascular features

G. Frisoni, S. Galluzzi, C. Geroldi, 2002, Journal of Neurology.

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

Giovanni B. Frisoni, Gunhild Waldemar, Juha O. Rinne, 2017, Alzheimer's & Dementia.

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’

J. Molinuevo, O. Blin, J. Pariente, 2016, Journal of internal medicine.

Brain network modulation in Alzheimer's and frontotemporal dementia with transcranial electrical stimulation

G. Frisoni, Lorenzo Pini, M. Pievani, 2021, Neurobiology of Aging.

Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects

Magda Tsolaki, Paolo Maria Rossini, Giovanni B. Frisoni, 2014, NeuroImage.

Validation Study of a CT-Based Weighted Rating Scale for Subcortical Ischemic Vascular Disease in Patients with Mild Cognitive Deterioration

G. Frisoni, C. Testa, S. Galluzzi, 2003, European Neurology.

Distinctive Clinical Features of Mild Cognitive Impairment with Subcortical Cerebrovascular Disease

Giovanni B. Frisoni, Orazio Zanetti, Samantha Galluzzi, 2005, Dementia and Geriatric Cognitive Disorders.

Markers of Alzheimer's disease in a population attending a memory clinic

G. Frisoni, S. Galluzzi, G. Amicucci, 2009, Alzheimer's & Dementia.

Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome.

G. Frisoni, S. Galluzzi, C. Geroldi, 2002, Journal of neurology.

Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo

Paul M. Thompson, Giovanni B. Frisoni, Michela Pievani, 2009, NeuroImage.

Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's Disease.

Roland Opfer, Simone Lista, Enrica Cavedo, 2017, Journal of Alzheimer's disease : JAD.

Diagnosis Disclosure of Prodromal Alzheimer Disease-Ethical Analysis of Two Cases

G. Frisoni, S. Galluzzi, C. Geroldi, 2010, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

BRONCHIAL CARCINOMA : A STATISTICAL STUDY OF 741 NECROPSIES WITH SPECIAL REFERENCE TO THE DISTRIBUTION OF BLOOD-BORNE METASTASES

S. Galluzzi, P. Payne, 2007 .

CSF BIOMARKERS AND EFFECT OF APOLIPOPROTEIN E GENOTYPE, AGE AND SEX ON CUT-OFF DERIVATION IN MILD COGNITIVE IMPAIRMENT

P. Rossini, J. Molinuevo, O. Blin, 2017, Alzheimer's & Dementia.

Cardiac autonomic dysfunction is associated with white matter lesions in patients with mild cognitive impairment.

Giovanni B. Frisoni, Cristina Geroldi, Samantha Galluzzi, 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset

Stephen F. Carter, W. M. van der Flier, P. Scheltens, 2019, Journal of Neurology.

Characterization of cognitive function with the cantab in individuals with amnestic mild cognitive impairment in relation to hippocampal volume, amyloid, and tau status: Preliminary baseline results from the PharmaCog/european-ADNI study

P. Rossini, J. Molinuevo, O. Blin, 2015, Alzheimer's & Dementia.

Visual assessment of medial temporal atrophy on MR films in Alzheimer’s disease: comparison with volumetry

Cristina Geroldi, Alberto Beltramello, Hilkka Soininen, 2005, Aging clinical and experimental research.

The frequency and influence of dementia risk factors in prodromal Alzheimer's disease

P. Scheltens, W. Maier, G. Frisoni, 2017, Neurobiology of Aging.

Drug Treatment of REM Sleep Behavior Disorders in Dementia With Lewy Bodies

G. Frisoni, S. Galluzzi, Gloria Massironi, 2003, International Psychogeriatrics.

Prescription practices of diagnostic imaging in dementia: a survey of 47 Alzheimer's Centres in Northern Italy

P. Pasqualetti, G. Frisoni, S. Galluzzi, 2003, International journal of geriatric psychiatry.

miR-146a Plasma Levels Are Not Altered in Alzheimer’s Disease but Correlate With Age and Illness Severity

S. Galluzzi, C. Geroldi, O. Zanetti, 2020, Frontiers in Aging Neuroscience.

Temporal lobe asymmetry in patients with Alzheimer's disease with delusions

G. Frisoni, S. Galluzzi, C. Geroldi, 2000, Journal of neurology, neurosurgery, and psychiatry.

The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment

G. Frisoni, S. Galluzzi, G. Amicucci, 2010, Alzheimer's & Dementia.

Vascular damage and EEG markers in subjects with mild cognitive impairment

C. Miniussi, P. M. Rossini, D. V. Moretti, 2007, Clinical Neurophysiology.

CROSS-SECTIONAL BIOMARKER CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT PATIENTS IN WP5 PHARMACOG/E-ADNI STUDY

P. Rossini, J. Molinuevo, O. Blin, 2014, Alzheimer's & Dementia.

CSF Beta-Amyloid and APOE E4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study

P. Rossini, J. Molinuevo, O. Blin, 2016 .

PT593. CSF Beta-Amyloid and APOE E4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study

P. Rossini, O. Blin, J. Pariente, 2016, International Journal of Neuropsychopharmacology.

Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study

A. Owens, P. Visser, M. Tsolaki, 2023, PLoS ONE.

An old nun with diabetes who should not have been moved from her nunnery

G. Frisoni, S. Galluzzi, C. Geroldi, 2001, Journal of The American Geriatrics Society.

Brain volumes in healthy adults aged 40 years and over: a voxel-based morphometry study

Giovanni B. Frisoni, Andrea Falini, Alberto Beltramello, 2005, Aging clinical and experimental research.

Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.

J. Molinuevo, J. Jovicich, G. Frisoni, 2019, Journal of Alzheimer's disease : JAD.

White matter damage in Alzheimer disease and its relationship to gray matter atrophy.

G. Frisoni, M. Filippi, F. Agosta, 2011, Radiology.

Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly

G. Frisoni, S. Galluzzi, O. Zanetti, 2017, Neurobiology of Aging.

Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE ϵ4 carriers

C. Beckmann, G. Frisoni, N. Filippini, 2009, Journal of Magnetic Resonance Imaging.

CSF BETA-AMYLOID- AND APOE Ɛ4-RELATED DECLINE IN EPISODIC MEMORY OVER 12 MONTHS MEASURED USING THE CANTAB IN INDIVIDUALS WITH AMNESTIC MCI: RESULTS FROM THE EUROPEAN ADNI STUDY

P. Rossini, J. Molinuevo, O. Blin, 2016, Alzheimer's & Dementia.

Preliminary Evidence of Validity of the Revised Criteria for Alzheimer Disease Diagnosis: Report of 2 Cases

D. Perani, G. Frisoni, S. Galluzzi, 2010, Alzheimer disease and associated disorders.

Autonomic dysfunction in mild cognitive impairment: a transcranial Doppler study

S. Galluzzi, Giovanni B. Frisoni, Sara Mazzucco, 2011, Acta neurologica Scandinavica.

Validation Study of the Three-Objects-Three-Places Test: A Screening Test for Alzheimer's Disease

G. Frisoni, S. Galluzzi, C. Geroldi, 2006, Experimental aging research.

Distinct cerebrospinal fluid amyloid‐beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia

G. Frisoni, S. Galluzzi, G. Amicucci, 2012, Electrophoresis.

Cognitive, psychological, and physiological effects of a web-based mindfulness intervention in older adults during the COVID-19 pandemic: an open study

M. Pievani, S. Galluzzi, M. Lanfredi, 2024, BMC geriatrics.

Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset

Stephen F. Carter, W. M. van der Flier, P. Scheltens, 2019, Journal of Neurology.

Nucleus Accumbens atrophy in early-and late-onset Alzheimer ’ s disease

G. Frisoni, M. Pievani, M. Bocchetta, 2012 .

Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo

G. Frisoni, F. Sabattoli, M. Pievani, 2009, NeuroImage.